Why Your Behavior, Not Just Your Airways, Shapes Sleep Trouble at High Altitude

When people sleep at altitude, their breathing often becomes irregular, fragmented, and periodically interrupted by pauses that would raise immediate red flags in any sleep laboratory at sea level. Clinicians have long interpreted this phenomenon, known as altitude-related sleep-disordered breathing, almost exclusively through the lens of physiology: thinner air, lower oxygen pressure, and a destabilized respiratory control system that swings between overbreathing and underbreathing through the night. A new letter to the editor published in the Journal of Clinical Sleep Medicine argues that this picture, while scientifically sound, is incomplete. A team of Indonesian researchers led by Nining Maizura of Universitas Negeri Malang contends that behavior, perception, and health-seeking habits deserve a seat at the interpretive table alongside hypoxia and chemoreceptor dynamics.

The letter, published on 24 August 2026 as volume 22, article 145 of the journal, is framed as a response to a randomized crossover trial by Deflorin and colleagues that examined the effect of short-term descent to low altitude in healthy residents living at moderate altitude. That trial addressed a genuinely important question: whether periodic dips into lowland conditions can reset the respiratory disturbances that accumulate during chronic residence at elevation. The letter writers do not dispute the physiological value of such work. Instead, they argue that the interpretation of altitude-related sleep-disordered breathing has been too narrowly physiological, and that a behavioral perspective can explain why identical hypoxic exposures produce wildly different clinical outcomes in different people.

The technical core of the physiological account is well established. As barometric pressure falls with altitude, the partial pressure of inspired oxygen drops, arterial oxygen saturation declines, and the peripheral chemoreceptors in the carotid bodies respond by driving ventilation upward. This increased ventilation washes out carbon dioxide, and because carbon dioxide is the primary stimulus for the central respiratory controller during sleep, the system can overshoot into hypocapnia. Below a critical threshold of carbon dioxide tension, the brainstem temporarily halts the drive to breathe, producing central apneas. Oxygen desaturation then reactivates the chemoreflex, ventilation surges again, and the cycle repeats in the stereotyped waxing-and-waning pattern of periodic breathing. This loop explains why even healthy, non-snoring mountaineers can experience apnea indices at altitude that would satisfy diagnostic criteria for sleep apnea at sea level.

What the physiological model struggles to explain, the authors argue, is variability. Not everyone at the same altitude develops the same severity of sleep-disordered breathing, and not everyone who does develops the symptoms, distress, or functional impairment that the objective measurements might predict. The letter points toward a growing literature showing that how people perceive their sleep, how they interpret their symptoms, and whether they seek help are powerful modifiers of clinical reality. A cited study by Duarte and colleagues on adults with suspected obstructive sleep apnea found that perceptions of sleep duration frequently diverge from objectively measured sleep, a mismatch that can distort both diagnosis and the perceived need for treatment. If perception can decouple from measurement in ordinary clinic populations, the authors reason, it can do so even more dramatically in the unusual and poorly understood context of altitude.

The behavioral argument also draws on qualitative research into help-seeking. A 2026 study by Bhaskaran and colleagues of undergraduate medical students explored perceived risk, symptoms, and help-seeking behavior for obstructive sleep apnea, and found that even among people with medical training, recognition of sleep-disordered breathing as a condition warranting evaluation was far from automatic. Stigma, minimization of snoring and witnessed apneas, and simple unfamiliarity with the disorder all delayed presentation. Translated to altitude settings, this suggests that residents of mountainous regions, migrants to high-elevation cities, and even transient visitors such as trekkers and workers may systematically under-recognize or misattribute their nocturnal breathing disturbances, chalking them up to strange beds, cold air, travel fatigue, or stress rather than to a measurable and manageable physiological phenomenon.

Adherence adds a second behavioral layer. The letter cites the classic qualitative work of Sawyer and colleagues, who documented profound differences in how adherent and non-adherent patients perceived their obstructive sleep apnea diagnosis and continuous positive airway pressure therapy. Non-adherers described masks as uncomfortable, benefits as intangible, and the diagnosis itself as ambiguous, while adherers reported noticeable daytime improvement that reinforced continued use. The implication for altitude medicine is direct: interventions for altitude-related sleep-disordered breathing, whether oxygen supplementation, medications such as acetazolamide, or descent itself, succeed or fail partly on behavioral grounds. A therapy that is physiologically elegant but behaviorally unacceptable will not be used, and an interpretation of the disorder that ignores this fact will mispredict outcomes.

The letter’s authors, who span five Indonesian universities including Universitas Sebelas Maret, Universitas Islam Balitar, Universitas Kanjuruhan Malang, and Universitas Negeri Surabaya, bring a perspective shaped by a country whose territory includes both densely populated lowlands and significant highland communities. Indonesia’s highland populations, along with the millions of people worldwide who live above 1,500 meters in the Andes, the Himalayas, the Ethiopian Highlands, and the mountainous American West, represent a substantial global population for whom altitude-related sleep disturbances are a nightly reality rather than an expedition curiosity. For these communities, the question of whether periodic breathing is a benign acclimatization phenomenon or a clinically meaningful disorder is not academic; it shapes whether people seek care, whether physicians look for it, and whether health systems allocate resources to it.

The behavioral perspective also reframes the interpretation of research findings such as the Deflorin descent trial. If short-term descent improves sleep-disordered breathing in moderate-altitude residents, the clinical significance of that improvement depends on what residents actually experience and do. Someone who perceives their altitude sleep as restorative may report better daytime function regardless of modest changes in apnea-hypopnea indices, while someone who has learned to fear their fragmented sleep may experience persistent insomnia symptoms even after objective respiratory parameters normalize. Perception, expectation, and coping behavior can amplify or dampen the functional consequences of the same physiological signal, which means that trials measuring only respiratory variables may systematically underestimate or mischaracterize the benefits of interventions.

There is also a diagnostic dimension to the argument. Standard sleep apnea criteria were developed and validated at or near sea level, and applying them uncritically at altitude risks pathologizing adaptive responses such as periodic breathing that may carry little long-term harm in otherwise healthy residents. Conversely, a purely physiological interpretation risks missing the minority of altitude dwellers whose sleep-disordered breathing is compounded by anatomical obstruction, obesity, or overt heart failure, and who would benefit most from intervention. Behavioral information, including symptom perception, functional impact, and help-seeking readiness, can help clinicians distinguish adaptive periodic breathing from clinically significant disease in ways that oximetry traces alone cannot.

The letter, whose authors report no funding and no competing interests, does not present new experimental data; no datasets were generated or analyzed in its preparation. Its contribution is conceptual, urging the sleep medicine community to widen its interpretive frame. In an era when portable sleep monitoring makes it feasible to study breathing in remote highland homes rather than laboratories, the authors suggest that future studies should pair physiological measurements with validated assessments of sleep perception, symptom attribution, and treatment attitudes. Such integrated designs could finally explain why two people with identical desaturation profiles at the same altitude can inhabit utterly different clinical worlds, one sleeping soundly through periodic breathing and the other suffering through every fragmented night. The message is a humbling one for a field built on chemoreflex loops and pressure gradients: the air explains the apnea, but human behavior explains the disease.

Subject of Research: Behavioral influences on sleep-disordered breathing at high altitude

Article Title: Broadening the interpretation of altitude-related sleep-disordered breathing: a behavioral perspective

Article References: Broadening the interpretation of altitude-related sleep-disordered breathing: a behavioral perspective. (n.d.). https://doi.org/10.1007/s44470-026-00172-x

Image Credits: AI Generated

DOI: 10.1007/s44470-026-00172-x

Keywords: sleep-disordered breathing, high altitude, periodic breathing, obstructive sleep apnea, hypoxia, sleep perception, CPAP adherence, help-seeking behavior, altitude medicine, respiratory physiology, Journal of Clinical Sleep Medicine, behavioral health